The authors declare that they have no conflicts of interest.
Ethical approval
Ethics approval was waived by the Institutional Review Board of St. Petersburg State University, Saint Petersburg, Russian Federation, as this study is a literature review involving no experimental procedures on patients.
Consent to participate
Figure 1 is taken from clinical practice; patient consent was obtained.
Consent to publication
The unpublished clinical images included in this article were obtained from patients treated at St. Petersburg State University, Saint Petersburg, Russian Federation. Written informed consent for the publication of these images was obtained from all patients. All images were anonymized prior to publication.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
References
Lamas GA, Mitchell GF, Flaker GC, Smith SC Jr, Gersh BJ, Basta L, et al. Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators.Circulation. 1997;96:827–33. [DOI] [PubMed]
Tcheng JE, Jackman JD Jr, Nelson CL, Gardner LH, Smith LR, Rankin JS, et al. Outcome of Patients Sustaining Acute Ischemic Mitral Regurgitation during Myocardial Infarction.Ann Intern Med. 1992;117:18–24. [DOI] [PubMed]
Bursi F, Enriquez-Sarano M, Jacobsen SJ, Roger VL. Mitral Regurgitation After Myocardial Infarction: A Review.Am J Med. 2006;119:103–12. [DOI] [PubMed]
Kim BJ, Kim YS, Kim HJ, Ju MH, Kim JB, Jung SH, et al. Concomitant mitral valve surgery in patients with moderate ischemic mitral regurgitation undergoing coronary artery bypass grafting.J Thorac Dis. 2018;10:3632–42. [DOI] [PubMed] [PMC]
Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Tribouilloy C, et al.; European Association of Echocardiography. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease).Eur J Echocardiogr. 2010;11:307–32. [DOI] [PubMed]
Grigioni F, Enriquez-Sarano M, Zehr K, Bailey K, Tajik A. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment.Circulation. 2001;103:1759–64. [DOI] [PubMed]
Fattouch K, Guccione F, Sampognaro R, Panzarella G, Corrado E, Navarra E, et al. POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: A randomized trial.J Thorac Cardiovasc Surg. 2009;138:278–85. [DOI] [PubMed]
Michler RE, Smith PK, Parides MK, Ailawadi G, Thourani V, Moskowitz AJ, et al. Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation.N Engl J Med. 2016;374:1932–41. [DOI] [PubMed] [PMC]
Praz F, Borger MA, Lanz J, Marin-Cuartas M, Abreu A, Adamo M, et al.; ESC/EACTS Scientific Document Group. 2025 ESC/EACTS Guidelines for the management of valvular heart disease.Eur Heart J. 2025;46:4635–736. [DOI] [PubMed]
Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation. 2021;143:e35–71. [DOI] [PubMed]
Spieker M, Sidabras J, Lagarden H, Christian L, Günther N, Angendohr S, et al. Exercise-Induced Dynamic Mitral Regurgitation is Associated with Outcomes in Patients with Ischaemic Cardiomyopathy.ESC Heart Fail. 2025;12:1883–92. [DOI] [PubMed] [PMC]
Penicka M, Linkova H, Lang O, Fojt R, Kocka V, Vanderheyden M, et al. Predictors of Improvement of Unrepaired Moderate Ischemic Mitral Regurgitation in Patients Undergoing Elective Isolated Coronary Artery Bypass Graft Surgery.Circulation. 2009;120:1474–81. [DOI] [PubMed]
Altarabsheh SE, Deo SV, Dunlay SM, Erwin PJ, Obeidat YM, Navale S, et al. Meta-Analysis of Usefulness of Concomitant Mitral Valve Repair or Replacement for Moderate Ischemic Mitral Regurgitation With Coronary Artery Bypass Grafting.Am J Cardiol. 2017;119:734–41. [DOI] [PubMed]
Chan KM, Punjabi PP, Flather M, Wage R, Symmonds K, Roussin I, et al. Coronary Artery Bypass Surgery With or Without Mitral Valve Annuloplasty in Moderate Functional Ischemic Mitral Regurgitation.Circulation. 2012;126:2502–10. [DOI] [PubMed]
Piérard LA, Carabello BA. Ischaemic mitral regurgitation: pathophysiology, outcomes and the conundrum of treatment.Eur Heart J. 2010;31:2996–3005. [DOI] [PubMed]
Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ. Determinants of the Degree of Functional Mitral Regurgitation in Patients With Systolic Left Ventricular Dysfunction.Circulation. 2000;102:1400–6. [DOI] [PubMed]
Rahmouni K, Shahinian JH, Deng M, Qureshi S, Chikwe J, Chan V. Ischemic mitral regurgitation: when should one intervene?Curr Opin Cardiol. 2021;36:755–63. [DOI] [PubMed]
Bax JJ, Braun J, Somer ST, Klautz R, Holman ER, Versteegh MI, et al. Restrictive Annuloplasty and Coronary Revascularization in Ischemic Mitral Regurgitation Results in Reverse Left Ventricular Remodeling.Circulation. 2004;110:II103–8. [DOI] [PubMed]
Piatkowski R, Kochanowski J, Budnik M, Peller M, Grabowski M, Opolski G. Stress Echocardiography Protocol for Deciding Type of Surgery in Ischemic Mitral Regurgitation: Predictors of Mitral Regurgitation Recurrence following CABG Alone.J Clin Med. 2021;10:4816. [DOI] [PubMed] [PMC]
Yoran C, Yellin EL, Becker RM, Gabbay S, Frater RW, Sonnenblick EH. Dynamic aspects of acute mitral regurgitation: effects of ventricular volume, pressure and contractility on the effective regurgitant orifice area..Circulation. 1979;60:170–6. [DOI] [PubMed]
Rosario LB, Stevenson LW, Solomon SD, Lee RT, Reimold SC. The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size.J Am Coll Cardiol. 1998;32:1819–24. [DOI] [PubMed]
Lebrun F, Lancellotti P, Piérard LA. Quantitation of functional mitral regurgitation during bicycle exercise in patients with heart failure.J Am Coll Cardiol. 2001;38:1685–92. [DOI] [PubMed]
Sellers RD, Levy MJ, Amplatz K, Lillehei CW. Left retrograde cardioangiography in acquired cardiac disease.Am J Cardiol. 1964;14:437–47. [DOI] [PubMed]
Bargiggia GS, Tronconi L, Sahn DJ, Recusani F, Raisaro A, De Servi S, et al. A new method for quantitation of mitral regurgitation based on color flow Doppler imaging of flow convergence proximal to regurgitant orifice..Circulation. 1991;84:1481–9. [DOI] [PubMed]
Enriquez-Sarano M, Miller FA Jr, Hayes SN, Bailey KR, Tajik AJ, Seward JB. Effective mitral regurgitant orifice area: Clinical use and pitfalls of the proximal isovelocity surface area method.J Am Coll Cardiol. 1995;25:703–9. [DOI] [PubMed]
Hall SA, Brickner ME, Willett DL, Irani WN, Afridi I, Grayburn PA. Assessment of Mitral Regurgitation Severity by Doppler Color Flow Mapping of the Vena Contracta.Circulation. 1997;95:636–42. [DOI] [PubMed]
Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography.J Am Soc Echocardiogr. 2003;16:777–802. [DOI] [PubMed]
American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease.Circulation. 2006;114:e84–231. [DOI] [PubMed]
Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease.Circulation. 2008;118:e523–661. [DOI] [PubMed]
Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, et al. Quantitative Determinants of the Outcome of Asymptomatic Mitral Regurgitation.N Engl J Med. 2005;352:875–83. [DOI] [PubMed]
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary.Circulation. 2014;129:2440–92. [DOI] [PubMed]
Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS); Vahanian A, Alfieri O, Andreotti F, Antunes MJ, et al. Guidelines on the management of valvular heart disease (version 2012).Eur Heart J. 2012;33:2451–96. [DOI] [PubMed]
Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease.Eur Heart J. 2017;38:2739–91. [DOI] [PubMed]
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease.Eur Heart J. 2021;43:561–632. [DOI] [PubMed]
Grayburn PA, Sannino A, Packer M. Proportionate and Disproportionate Functional Mitral Regurgitation.JACC: Cardiovasc Imaging. 2019;12:353–62. [DOI] [PubMed]
Zagatina A, Ciampi Q, Boshchenko A, Rodriguez-Zanella H, Padang R, Bursi F, et al. Moderate ischemic mitral regurgitation at rest is associated with multiple functional vulnerabilities during exercise stress echocardiography.Int J Cardiovasc Imaging. 2026;42:1113–23. [DOI] [PubMed]
Lancellotti P, Gérard PL, Piérard LA. Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation.Eur Heart J. 2005;26:1528–32. [DOI] [PubMed]
Piérard LA, Lancellotti P. The Role of Ischemic Mitral Regurgitation in the Pathogenesis of Acute Pulmonary Edema.N Engl J Med. 2004;351:1627–34. [DOI] [PubMed]
Lancellotti P, Troisfontaines P, Toussaint AC, Pierard LA. Prognostic Importance of Exercise-Induced Changes in Mitral Regurgitation in Patients With Chronic Ischemic Left Ventricular Dysfunction.Circulation. 2003;108:1713–7. [DOI] [PubMed]
Piérard LA, Lancellotti P. Stress testing in valve disease.Heart. 2007;93:766–72. [DOI] [PubMed] [PMC]
Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, et al. Transcatheter Mitral-Valve Repair in Patients with Heart Failure.N Engl J Med. 2018;379:2307–18. [DOI] [PubMed]
Lancellotti P, Pibarot P, Chambers J, La Canna G, Pepi M, Dulgheru R, et al. Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper.Eur Heart J Cardiovasc Imaging. 2022;23:e171–232. [DOI] [PubMed]
Lancellotti P, Magne J, Dulgheru R, Ancion A, Martinez C, Piérard LA. Clinical Significance of Exercise Pulmonary Hypertension in Secondary Mitral Regurgitation.Am J Cardiol. 2015;115:1454–61. [DOI] [PubMed]
Detaint D, Messika-Zeitoun D, Avierinos JF, Scott C, Chen H, Burnett JC Jr, et al. B-Type Natriuretic Peptide in Organic Mitral Regurgitation.Circulation. 2005;111:2391–7. [DOI] [PubMed]
Sutton TM, Stewart RA, Gerber IL, West TM, Richards AM, Yandle TG, et al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation.J Am Coll Cardiol. 2003;41:2280–7. [DOI] [PubMed]
Pizarro R, Bazzino OO, Oberti PF, Falconi M, Achilli F, Arias A, et al. Prospective Validation of the Prognostic Usefulness of Brain Natriuretic Peptide in Asymptomatic Patients With Chronic Severe Mitral Regurgitation.J Am Coll Cardiol. 2009;54:1099–106. [DOI] [PubMed]
Kerr AJ, Raffel OC, Whalley GA, Zeng I, Stewart RA. Elevated B-type natriuretic peptide despite normal left ventricular function on rest and exercise stress echocardiography in mitral regurgitation.Eur Heart J. 2008;29:363–70. [DOI] [PubMed]
Grewal J, Mankad S, Freeman WK, Click RL, Suri RM, Abel MD, et al. Real-Time Three-Dimensional Transesophageal Echocardiography in the Intraoperative Assessment of Mitral Valve Disease.J Am Soc Echocardiogr. 2009;22:34–41. [DOI] [PubMed]
Kahlert P, Plicht B, Schenk IM, Janosi RA, Erbel R, Buck T. Direct Assessment of Size and Shape of Noncircular Vena Contracta Area in Functional Versus Organic Mitral Regurgitation Using Real-Time Three-Dimensional Echocardiography.J Am Soc Echocardiogr. 2008;21:912–21. [DOI] [PubMed]
Uretsky S, Gillam L, Lang R, Chaudhry FA, Argulian E, Supariwala A, et al. Discordance Between Echocardiography and MRI in the Assessment of Mitral Regurgitation Severity.J Am Coll Cardiol. 2015;65:1078–88. [DOI] [PubMed]
Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction.N Engl J Med. 2000;343:1445–53. [DOI] [PubMed]
Levine RA, Schwammenthal E. Ischemic Mitral Regurgitation on the Threshold of a Solution.Circulation. 2005;112:745–58. [DOI] [PubMed]
McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure.N Engl J Med. 2014;371:993–1004. [DOI] [PubMed]
Kang DH, Park SJ, Shin SH, Hong GR, Lee S, Kim MS, et al. Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation.Circulation. 2019;139:1354–65. [DOI] [PubMed]
Mullens W, Martens P. Sacubitril/Valsartan to Reduce Secondary Mitral Regurgitation.Circulation. 2019;139:1366–70. [DOI] [PubMed]
McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.N Engl J Med. 2019;381:1995–2008. [DOI] [PubMed]
Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.N Engl J Med. 2020;383:1413–24. [DOI] [PubMed]
Bodea OM, Serban S, Craciun ML, Mateescu DM, Florescu E, Muresan CO, et al. Effects of SGLT2 Inhibitors on Clinical Outcomes, Symptoms, Functional Capacity, and Cardiac Remodeling in Heart Failure: A Comprehensive Systematic Review and Multidomain Meta-Analysis of Randomized Trials.J Clin Med. 2026;15:378. [DOI] [PubMed] [PMC]
Schaff HV, Nguyen A. Contemporary techniques for mitral valve repair—the Mayo Clinic experience.Indian J Thorac Cardiovasc Surg. 2019;36:18–26. [DOI] [PubMed] [PMC]
Kuralay E. Mitral ring annuloplasty by biological material.Turk J Thorac Cardiovasc Surg. 2022;30:645–8. [DOI] [PubMed] [PMC]
Chotivatanapong T. Mitral annuloplasty ring design and selection: Complete semi-rigid is best.JTCVS Tech. 2021;10:55–7. [DOI] [PubMed] [PMC]
Del Forno B, Castiglioni A, Sala A, Geretto A, Giacomini A, Denti P, et al. Mitral valve annuloplasty.Multimed Man Cardio-thorac Surg. 2017:2017. [DOI] [PubMed]
Kubota K, Otsuji Y, Ueno T, Koriyama C, Levine RA, Sakata R, et al. Functional mitral stenosis after surgical annuloplasty for ischemic mitral regurgitation: Importance of subvalvular tethering in the mechanism and dynamic deterioration during exertion.J Thorac Cardiovasc Surg. 2010;140:617–23. [DOI] [PubMed] [PMC]
Ereminiene E, Vaskelyte J, Benetis R, Stoskute N. Ischemic Mitral Valve Repair: Predictive Significance of Restrictive Left Ventricular Diastolic Filling.Echocardiography. 2005;22:217–24. [DOI] [PubMed]
Ryadinsky ME, Filippov AA, Kamenskikh MS, Kim GI, Kappushev RY, Provotorova JD, et al. Modern challenges of surgical management of patients with moderate and borderline ischemic mitral regurgitation.Sib J Clin Exp Med. 2024;39:46–57. [DOI]
Deja MA, Grayburn PA, Sun B, Rao V, She L, Krejca M, et al. Influence of Mitral Regurgitation Repair on Survival in the Surgical Treatment for Ischemic Heart Failure Trial.Circulation. 2012;125:2639–48. [DOI] [PubMed] [PMC]
Kopjar T, Gasparovic H, Mestres CA, Milicic D, Biocina B. Meta-analysis of concomitant mitral valve repair and coronary artery bypass surgery versus isolated coronary artery bypass surgery in patients with moderate ischaemic mitral regurgitation.Eur J Cardio-Thorac Surg. 2016;50:212–22. [DOI] [PubMed]
Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, et al. Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation.N Engl J Med. 2018;379:2297–306. [DOI] [PubMed]
Bouchard D, Jensen H, Carrier M, Demers P, Pellerin M, Perrault LP, et al. Effect of systematic downsizing rigid ring annuloplasty in patients with moderate ischemic mitral regurgitation.J Thorac Cardiovasc Surg. 2014;147:1471–7. [DOI] [PubMed]
Smith PK, Puskas JD, Ascheim DD, Voisine P, Gelijns AC, Moskowitz AJ, et al. Surgical Treatment of Moderate Ischemic Mitral Regurgitation.N Engl J Med. 2014;371:2178–88. [DOI] [PubMed] [PMC]